Selinexor Shows Promising Clinical Results in Advanced Solid Tumors, Paving Way for Future Myeloma Trials
Newton, Massachusetts-based Karyopharm Therapeutics has published the results from its…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
‘Moving Mountains for Multiple Myeloma’ Hikes Grand Canyon to Raise Research Money
Three organizations — CURE Media Group, Multiple Myeloma…
BMS, AbbVie Announce EC Approval of Empliciti For Multiple Myeloma
Bristol-Myers Squibb (BMS) Company and AbbVie have…
ICER Analyzes Cost and Value of Drugs Used to Treat Multiple Myeloma in New Report
The Institute for Clinical and Economic Review (ICER),…
Phase 3 Study of Ixazomib in Select Multiple Myeloma Patients Reports Benefits
Takeda Pharmaceutical Co. has announced that Ninlaro (ixazomib),…
Researchers Develop New Animal Model of Multiple Myeloma
Researchers in the Sylvester Comprehensive Cancer Center at the…
